2023 FARA Fellows
The FARA Fellow Program recognizes young investigators who will commit their early career to FA research and want to grow their profile ...
News & Blog
News & Blog
Meet the Community – Robbi Van Schoick
Meet the Community – Duncan Collins
Larimar Therapeutics Receives FDA Clearance
Larimar Therapeutics Receives FDA Clearance to Proceed to 50 mg Cohort in CTI-1601’s Phase 2 Friedreich’s Ataxia Trial and to Initiate Open Label Extension Trial
Meet the Community – Kiara Lynch–Owen
Meet the Community – Tricia Herman-Maul
Meet the Community 2: A Closer Look – Abby G
Lexeo Therapeutics Announces Completion of First Cohort and Dosing in Second Cohort in SUNRISE-FA, a Phase 1/2 Clinical Trial of LX2006 for the Treatment of Friedreich’s Ataxia Cardiomyopathy
FARA Celebrates the 15th Annual Ataxian Athlete Initiative (AAI) for People with Ataxia
May 2023 – Advocacy Newsletters
